Business
Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference
Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n LAS VEGAS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired biopharmaceutical development company, today announced that their President and Chief Science Officer, Dr. Andrea Small-Howard, will deliver their company presentation during the Healthcare & Biotech Track at the H.C. Wainwright 23rd Annual Global Investment Conference, to be held virtually from September 13 to September 15, 2021. Dr. Small-Howard will provide an overview of Gb Sciences' drug development pipeline of novel plant-inspired pharmaceuticals for COVID-related cytokine release syndrome, chronic pain, and Parkinson's disease and highlight their strategic advantages, including PhAROS™, their proprietary, AI-enabled drug discovery platform. For the first time, Dr. Small-Howard will present results from their recent proof-of-concept study on cytokine release syndrome therapies designed to suppress COVID-related hyperinflammation. \"I'm incredibly honored and excited to present the strategic advantages of Gb Sciences' novel, plant-inspired biopharmaceutical pipeline, and I look forward to sharing the results of the new research we've conducted to validate our plant-inspired therapies for COVID-related cytokine release syndrome, Parkinson's disease, and chronic pain,\" said Dr. Small-Howard. \"We are optimistic about what these findings mean for the future development of plant-inspired pharmaceuticals as novel anti-inflammatory therapies for COVID-patients and for the treatment of many other serious medical conditions.\" Dr. Small-Howard and Dr. Michael Farley, President of Gb Sciences' Canadian subsidiary, GbS Global Biopharma, Inc., will also meet one-on-one with potential investors and development partners. The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7:00 AM ET on Monday, September 13, 2021. Click for Webcast Link Participants can register for the event at: http://www.hcwevents.com/annualconference To learn more about Gb Sciences and their involvement in the H.C. Wainwright 23rd Annual Global Investment Conference, please visit https://gbsciences.com About H.C. Wainwright & Co. H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to ...